Plant- Based Vaccines
The first vaccine-relevant protein produced in plants was not an antigen, but an antibody. The first plant engineering technology was authorised the concept of plant-based vaccines to motivate us to develop practical products in plant engineering but there are some problems in reaching the final results. Several industrial analysis teams are currently working on the employment of plant-based vaccines in each humans and animals.
- Edible vaccines
- Plant transformation
- Veterinary vaccine
- Plant-based vaccine
Related Conference of Plant- Based Vaccines
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
Plant- Based Vaccines Conference Speakers
Recommended Sessions
- Adaptive Immunity
- Advances in Immunology Tests
- Cancer and Childhood Vaccines
- DNA Vaccines
- Geriatric Immunization
- How deadly is Corona Virus
- HPV and RV Vaccines
- Human Vaccines-Infectious and Non- Infectious
- Immune Response to Viral Infection
- Immunizable Diseases and their Vaccines
- Immunology and Pathology
- Immunoresearch and Immunotechnology
- Next-Generation Vaccine Delivery Technologies
- Plant- Based Vaccines
- Society and Cultural aspects of Vaccine
- Travel Immunization
- Vaccination and Immunization
- Vaccination for Pregnant Women
- Vaccine Regulatory Issues
- Vaccines against Drugs
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)